Temmune Therapeutics

{
  "facts": [
    {
      "date": "2026-03-20",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 20/03/2026",
      "value": "20/03/2026",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-03-11",
      "type": "filing",
      "quote": "NEERGELEGD 11 MAART 2026",
      "value": "11/03/2026",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-02-12",
      "type": "board_meeting",
      "quote": "eenparige schriftelijke besluiten van de raad van bestuur van de vennootschap dd. 12 februari 2026",
      "value": "12/02/2026",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-02-12",
      "type": "general_meeting",
      "quote": "eenparig schriftelijke besluiten van de algemene vergadering van aandeelhouders van de vennootschap dd. 12 februari 2026",
      "value": "12/02/2026",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "officer_resignation",
      "quote": "einde van het mandaat van dhr. Tom Heyman als persoon belast met het dagelijks bestuur van de Vennootschap met ingang van 9 februari 2026",
      "value": {
        "role": "persoon belast met het dagelijks bestuur",
        "end_date": "2026-02-09"
      },
      "object": "e1",
      "subject": "e2",
      "_value_raw": {
        "role": "persoon belast met het dagelijks bestuur",
        "end_date": "09/02/2026"
      }
    },
    {
      "type": "filing_representative",
      "quote": "bijzondere volmacht te verlenen aan Christoph Michiels, Tine Bassens, Thomas Van de Wiele, Nicolas Bosschaerts, Simon Meyskens, evenals elke andere advocaat of werknemer van het advocatenkantoor Deloitte Legal - Lawyers BV... teneinde de genomen beslissingen te publiceren... alsook alle inschrijvingen... te bekomen en te dien einde ook alle stukken en akten te ondertekenen",
      "value": "publiceren beslissingen, inschrijvingen KBO, ondertekenen stukken",
      "object": "e1",
      "subject": "e9"
    },
    {
      "date": "2026-02-12",
      "type": "officer_appointment",
      "quote": "benoeming van de vennootschap LIFE of SCI BV... als CEO bestuurder van de Vennootschap, met ingang vanaf 12 februari 2026 voor een duurtijd van 6 jaar",
      "value": {
        "role": "CEO bestuurder",
        "term": "6 jaar",
        "start_date": "2026-02-12"
      },
      "object": "e1",
      "subject": "e3",
      "_value_raw": {
        "role": "CEO bestuurder",
        "term": "6 jaar",
        "start_date": "12/02/2026"
      }
    },
    {
      "type": "permanent_representative",
      "quote": "vast vertegenwoordigd door dhr. Joris De Maeyer",
      "value": null,
      "object": "e3",
      "subject": "e4"
    },
    {
      "type": "permanent_representative",
      "quote": "Participatiemaatschappij Vlaanderen NV, vast vertegenwoordigd door dhr. Tobias Wilms",
      "value": null,
      "object": "e7",
      "subject": "e8"
    },
    {
      "type": "filing_representative",
      "quote": "bijzondere volmacht te verlenen aan elke bestuurder van de Vennootschap en aan Christoph Michiets, Tine Bassens, Thomas Van de Wiele, Nicolas Bosschaerts, Simon Meyskens, en elke andere advocaat of werknemer van het advocatenkantoor Deloitte Legal - Lawyers BV... teneinde de genomen beslissingen te publiceren... alsook alle inschrijvingen... te bekomen en te dien einde ook alle stukken en akten te ondertekenen",
      "value": "publiceren beslissingen, inschrijvingen KBO, ondertekenen stukken",
      "object": "e1",
      "subject": "e9"
    }
  ],
  "act_meta": {
    "outcome": "corrected",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 5335,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0776.938.722",
      "kind": "company",
      "name": "Temmune Therapeutics",
      "attrs": {
        "seat": "Kardinaal Mercierplein 2 2800 Mechelen",
        "legal_form": "Naamloze vennootschap"
      }
    },
    {
      "id": "e2",
      "kbo": null,
      "kind": "person",
      "name": "Tom Heyman",
      "attrs": {}
    },
    {
      "id": "e3",
      "kbo": "0563.547.828",
      "kind": "company",
      "name": "LIFE of SCI BV",
      "attrs": {
        "seat": "Nonnenstraat 23, 2800 Mechelen"
      }
    },
    {
      "id": "e4",
      "kbo": null,
      "kind": "person",
      "name": "Joris De Maeyer",
      "attrs": {}
    },
    {
      "id": "e5",
      "kbo": null,
      "kind": "person",
      "name": "Keith Mccullagh",
      "attrs": {}
    },
    {
      "id": "e6",
      "kbo": null,
      "kind": "person",
      "name": "Roderick Verhelst",
      "attrs": {}
    },
    {
      "id": "e7",
      "kbo": null,
      "kind": "company",
      "name": "Participatiemaatschappij Vlaanderen NV",
      "attrs": {}
    },
    {
      "id": "e8",
      "kbo": null,
      "kind": "person",
      "name": "Tobias Wilms",
      "attrs": {}
    },
    {
      "id": "e9",
      "kbo": null,
      "kind": "org",
      "name": "Deloitte Legal - Lawyers BV",
      "attrs": {}
    }
  ]
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "HEYMAN Tom",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "REYN Dirk",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "HEYMAN Tom",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "WILMS Tobias",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0776.938.722",
    "name_full": "Temmune Therapeutics"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Andrew Lightfoot",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2025-04-01",
      "evidence_quote": "De aandeelhouders nemen hierbij kennis van en bekrachtigen het ontslag van dhr. Andrew Lightfoot, als bestuurder van de Vennootschap, met ingang vanaf 1 April 2025.",
      "discharge_granted": true
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Tom Heyman",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2025-04-07",
      "evidence_quote": "De aandeelhouders gaan vervolgens over tot de benoeming van dhr. Tom Heyman, als bestuurder van de Vennootschap, met ingang vanaf 7 April 2025 voor een duurtijd van 6 jaar."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Joris De Maeyer",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0563547828",
        "name": "LIFE of SCI",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2025-04-01",
      "evidence_quote": "De raad van bestuur besluit eenparig om LIFE of SCI, een besloten vennootschap naar Belgisch recht, met zete! te nonnenstraat 23, 2800 Mechelen, ingeschreven in het Rechtspersonenregister bij de Kruispuntbank van Ondernemingen onder het nummer 0563.547.828 (RPR Antwerpen, afdeling Mechelen), vast ve"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0776.938.722",
    "name_full": "TEMMUNE THERAPEUTICS, AFGEKORT : TEMMUNETX",
    "legal_form": "NV"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": true,
    "object_change": true,
    "effective_date": "2025-01-21",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0776.938.722",
    "name_full": "TEMMUNE THERAPEUTICS, AFGEKORT : TEMMUNETX",
    "legal_form": "NV"
  },
  "signature_regime": "joint_two",
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 1940000.0,
      "currency": "EUR",
      "after_eur": null,
      "delta_eur": 1940000.0,
      "before_eur": null,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2024-09-23",
      "evidence_quote": "De vergadering beslist het eigen vermogen te verhogen ten belope van 1.940.000,00 EUR, door een inbreng in natura en door de uitgifte van 1.9400.000 aandelen",
      "contribution_type": "in_kind"
    },
    {
      "kind": "capital_increase",
      "amount": 1000000.0,
      "currency": "EUR",
      "after_eur": null,
      "delta_eur": 1000000.0,
      "before_eur": null,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2024-09-23",
      "evidence_quote": "De vergadering beslist het eigen vermogen te verhogen ten belope van 1.000.000,00 EUR, en beslist dat deze bijkomende inbreng zal verwezenlijkt worden door een inbreng in geld",
      "contribution_type": "cash"
    },
    {
      "kind": "capital_increase",
      "amount": 2980600.66,
      "currency": "EUR",
      "after_eur": 2980600.66,
      "delta_eur": 2980600.66,
      "before_eur": null,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2024-09-23",
      "evidence_quote": "Het geplaatst kapitaal bedraagt twee miljoen negenhonderdtachtigduizend zeshonderd euro en zesenzestig eurocent (\u20AC 2.980.600,66)",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0776.938.722",
    "name_full": "TEMMUNE THERAPEUTICS, AFGEKORT : TEMMUNETX",
    "legal_form": "CommV"
  }
}

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "statutaire",
      "new_address": {
        "city": "Vosselaar",
        "region": null,
        "street": "Roekendreef",
        "country": "BE",
        "postcode": "2350",
        "box_number": null,
        "street_number": "14"
      },
      "old_address": {
        "city": "Mechelen",
        "region": null,
        "street": "Goswin de Stassartstraat",
        "country": "BE",
        "postcode": "2800",
        "box_number": null,
        "street_number": "19"
      },
      "effective_date": "2023-08-31",
      "evidence_quote": "Op 31 augustus 2023 heeft de Beheerder Bioqube Factory Project Company CommV, vertegenwoordigd door haar vaste vertegenwoordiger Dirk Reyn, beslist om de zetel van de Vennootschap met onmiddellijke ingang te verplaatsen naar de Roekendreef 14 te 2350 Vosselaar."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0776.938.722",
    "name_full": "TEMMUNE THERAPEUTICS, AFGEKORT : TEMMUNETX",
    "legal_form": "CommV"
  }
}

{
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Luik",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2021-11-10",
    "filing_date": "2021-11-08",
    "act_kind_objet": "Oprichting"
  },
  "decision": {
    "body": "enig_aandeelhouder_schriftelijk",
    "date": "2021-10-29",
    "unanimous": true
  },
  "agm_change": {
    "new_schedule": "tweede vrijdag van de maand maart in 2023",
    "old_schedule": null,
    "effective_from_year": 2023,
    "rule_changes_summary": null
  },
  "detected_kind": "other_address_change",
  "other_address": {
    "action": "added",
    "purpose": "statutaire_zetel",
    "address_new": "Goswin de Stassartstraat 19, 2800 Mechelen",
    "address_old": null,
    "effective_date": "2021-10-29",
    "effective_date_is_approximate": false
  },
  "mandate_renewal": {
    "period_end": null,
    "mandate_kind": "beheerder",
    "period_start": "2021-10-29",
    "remuneration_eur": null,
    "remuneration_kind": "gratuit",
    "person_or_entity_kbo": null,
    "person_or_entity_name": "Bioqube Factory Project Company CommV"
  },
  "subject_company": {
    "kbo": "0776.938.722",
    "name_full": "Temmune Therapeutics",
    "legal_form": "CommV"
  },
  "accounts_deposit": {
    "filing_kind": null,
    "fiscal_year_end": "2022-12-31",
    "filing_reference": null
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Laura Sellenslagh",
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "Oprichtingsakte van de vennootschap",
    "Statuten van de vennootschap"
  ],
  "fiscal_year_change": {
    "new_end_mm_dd": "12-31",
    "old_end_mm_dd": null,
    "new_start_mm_dd": "01-01",
    "old_start_mm_dd": null,
    "first_full_new_year": 2022,
    "transition_period_end": "2022-12-31"
  },
  "liquidation_closure": null,
  "officer_designation": {
    "role": "beheerder",
    "organ": "bestuursorgaan",
    "person_name": "Dirk Reyn"
  },
  "special_procuration": null,
  "is_volet_a_only_stub": false,
  "vakbekwaamheid_change": null,
  "should_reroute_to_category": null,
  "single_shareholder_declaration": null
}